Patents

  
English | Català | Espaņol

 

 
We have not found a commercialised apotransferrin product. Nevertheless some companies have investigated how to produce it, and they have patented some apotransferrin manufacuring processes. Here you will find the most relevant patents related to the apotransferrin production. By linking the patent number you will access to the patent full description.
Home
        
 
PATENT N.
TITTLE
ASSIGNEE
INVENTOR
         
WO9749414A1
18-6-97
 MANUFACTURING PROCESS FOR THE PRODUCTION OF PURIFIED TRANSFERRIN ALPHA THERAPEUTIC CORPORATION, 5555 Valley Boulevard, Los Angeles, CA 90032, USA ROLF, John, M.; 600 N. McCadden Place, Los Angeles, CA 90004, USA.OHMIZU, Akimasa; 98 West Sandra Avenue, Arcadia, CA 91007, USA.LATHAM, Shawn, D.; 396 Groove Street, Sierra Madre, CA 91024, USA.BHATTACHARYA, Prabir; 300 Muirfield Lane, Walnut, CA 91789, USA

WO0001407A1
13-1-00
 PHARMACEUTICAL COMPOSITION COMPRISING HUMAN APOTRANSFERRIN AND PROCESS FOR MANUFACTURING OF THE COMPOSITION SUOMEN PUNAINEN RISTI VERIPALVELU, Kivihaantie 7, FIN-00310 Helsinki, Finland PARKKINEN, Jaakko; Liinasaarentie 21 B, FIN-02160 Espoo, Finland .VON BONSDORFF-LINDEBERG, Leni; Kirkkotie 14-16 A, FIN-02700 Kauniainen, Finland

US5041537
20-8-91
 "METHOD OF PREPARING A HIGH-PURITY, VIRUS SAFE, BIOLOGICALLY ACTIVE TRANSFERRIN PREPARATION BIOTEST PHARMA GmbH, Dreieich, Germany Bethke, Ulf; Babenhausen, Kothe, Norbert; Kronberg, Rudnick, Dieter; Rodermark, Moller, Wolfgang; Oberursel/Ts., Kloft, Michael; Darmstadt, (Germany)
US4841026
20-6-89
 VIRALLY INACTIVATED, NON-TOXIC, HUMAN TRANSFERRIN PREPARATION MILES LABORATORIES Inc., Elkhart, IN Van Beveren, Shirley M.; Concord, CA Pappenhagen, Albert R.; Concord, CA
WO03086272A3
23-10-03
 ULTRAPURE TRANSFERRIN FOR PHARMACEUTICAL COMPOSITIONS KAMADA LTD., Science Park, Kiryat Weizmann, 76327 Rehovot, Israel BAUER, Shabtai; 35 Shahal Street, 93702 Jerusalem, Israel
WO03086272A2
23-10-03
 ULTRAPURE TRANSFERRIN FOR PHARMACEUTICAL COMPOSITIONS KAMADA LTD., Science Park, Kiryat Weizmann, 76327 Rehovot, Israel BAUER, Shabtai; 35 Shahal Street, 93702 Jerusalem, Israel
US5744586
28-4-98
 MANUFACTURING PROCESS FOR THE PRODUCTION OF PURIFIED TRANSFERRIN ALPHA THERAPEUTIC CORPORATION, 5555 Valley Boulevard, Los Angeles, CA 90032, USA ROLF, John, M.; 600 N. McCadden Place, Los Angeles, CA 90004, USA.OHMIZU, Akimasa; 98 West Sandra Avenue, Arcadia, CA 91007, USA.LATHAM, Shawn, D.; 396 Groove Street, Sierra Madre, CA 91024, USA.BHATTACHARYA, Prabir; 300 Muirfield Lane, Walnut, CA 91789, USA
US6326473
4-12-01
 PHARMACEUTICAL PREPARATIONS SUOMEN PUNAINEN RISTI VERIPALVELU, Kivihaantie 7, FIN-00310 Helsinki, Finland PARKKINEN, Jaakko; Liinasaarentie 21 B, FIN-02160 Espoo, Finland .VON BONSDORFF-LINDEBERG, Leni; Kirkkotie 14-16 A, FIN-02700 Kauniainen, Finland
US6251860
26-6-01
 PHARMACEUTICAL PREPARATIONS SUOMEN PUNAINEN RISTI VERIPALVELU, Kivihaantie 7, FIN-00310 Helsinki, Finland PARKKINEN, Jaakko; Liinasaarentie 21 B, FIN-02160 Espoo, Finland .VON BONSDORFF-LINDEBERG, Leni; Kirkkotie 14-16 A, FIN-02700 Kauniainen, Finland
US4540573
10-9-85
 UNDENATURED VIRUS-FREE BIOLOGICALLY ACTIVE PROTEIN DERIVATIVES New York Blood Center, Inc., New York, NY Neurath, Alexander R.; New York, NYHorowitz, Bernard; New Rochelle, NY

AU5040999A1
24-1-00
 PHARMACEUTICAL COMPOSITION COMPRISING HUMAN APOTRANSFERRIN AND PROCESS FOR MANUFACTURING OF THE COMPOSITION SUOMEN PUNAINEN RISTI VERIPALVELU, Kivihaantie 7, FIN-00310 Helsinki, Finland PARKKINEN, Jaakko; Liinasaarentie 21 B, FIN-02160 Espoo, Finland .VON BONSDORFF-LINDEBERG, Leni; Kirkkotie 14-16 A, FIN-02700 Kauniainen, Finland
WO8500812A1
28-2-85
 CONJUGATES OF PROTEINS WITH ANTI-TUMOUR AGENTS Faulk, Ward P; EYLES, Christopher, Thomas Faulk, Ward P
WO9216227A1
1-10-92
 USE OF APOTRANSFERRIN WHICH HAS ACCUMULATED ZINC OR COPPER IONS TO COMBAT THE TOXIC ACTION OF ENDOTOXIN Nitsche, Dietrich; W-2300 Kiel 1, Germany Nitsche, Dietrich; W-2300 Kiel 1, Germany
WO8700756A1
12-2-87
 AGENTS FOR USE IN TUMOUR DIAGNOSIS, IMAGING, LOCALIZATION OR TREATMENT FAULK, Ward, Page FAULK, Ward, Page
US6274322
14-8-01
 COMPOSITION FOR INTRODUCING NUCLEIC ACID COMPLEXES INTO HIGHER EUCARYOTIC CELLS Boehringer Ingelheim International GmbH Germany Genentech, Inc., South San Francisco, CA The University of North Carolina at Chapel Hill, Chapel Hill, NC Curiel, David T.; Chapel Hill, NC F25 Birnstiel, Max L.;Cotten, Matthew;Wagner, Ernst; Langenzersdorf, Austria Zatloukal, Kurt;Plank, Christian;Oberhauser, Berndt;Schmidt, Walter G. M.;
US6126955
3-10-00
 APOTRANSFERRIN AS A POTENT INHIBITOR OF BACTERIAL ADHESION TO BIOMATERIALS University of Utah Research Foundation, Salt Lake City, UT Ardehali, Reza; Janatova, Jarmila; Mohammad, S. Fazal; Burns, Gregory L.; SALT LAKE CITY UT
US5441737
15-8-95
 USE OF APOTRANSFERRIN THAT HAS BOUND ZINC OR COPPER IONS FOR TREATMENT OF TOXIC EFFECTS OF ENDOTOXINS Nitsche, Dietrich; W-2300 Kiel 1, Germany Nitsche, Dietrich; W-2300 Kiel 1, Germany
US5254342
19-10-93
 COMPOSITIONS AND METHODS FOR ENHANCED TRANSEPITHELIAL AND TRANSENDOTHELIAL TRANSPORT OR ACTIVE AGENTS University of Southern California, Los Angeles, CA Shen, Wei-Chiang; San Marino, CA Wan, Jiansheng; Montery Park, CA
US4895714
23-1-90
 RADIOIODINATED APOTRANSFERRIN FOR USE IN TUMOR DIAGNOSIS, IMAGING, LOCALIZATION OR TREATMENT Faulk, Ward P Faulk, Ward P
US4886780
12-12-89
 CONJUGATES OF APOTRANSFERRIN PROTEINS WITH ANTITUMOR AGENTS Faulk, Ward P Faulk, Ward P
JP62010017A2
19-1-87
 PURIFICATION OF TRANSFERRINE RECEPTOR MOCHIDA PHARMACEUT CO LTD KOUGO YUTAKA; NISHISATO TAKUJI; KONDO HITOSHI; NIITSU YOJIRO; URUSHIZAKI ICHIRO
JP55120518A2
17-9-80
 PREVENTIVE AND CURING MEDICINE FOR BACTERIA INFECTIOUS DISEASE COMPRISING APOTRANSFERRIN AS ACTIVE INGREDIENT THE GREEN CROSS CORP DOI TAKUJI; NAKAJIMA TSUNETAKA; FUNAKOSHI SATORU
EP0533872B1
17-12-97
 USE OF APOTRANSFERRIN WHICH HAS ACCUMULATED ZINC OR COPPER IONS TO COMBAT THE TOXIC ACTION OF ENDOTOXIN Nitsche, Dietrich; W-2300 Kiel 1, Germany Nitsche, Dietrich; W-2300 Kiel 1, Germany
BG0051279A1
15-4-93
 METHOD FOR LABELLING APOTRANSFEREINE WITHZINC CHLORIDE MEDITSINSKA AKADEMIJA MUTAFCHIEV, DIMITAR A.; SIRAKOV, LJUBEN M.; Bulgaria
AT0161186E
15-1-98
 VERWENDUNG VON APOTRANSFERRIN, WELCHES ZINK ODER KUPFERIONEN ANGELAGERT HAT, ZUR BEKAEMPFUNG DER TOXISCHEN WIRKUNG DES ENDOTOXINS Nitsche, Dietrich; W-2300 Kiel 1, Germany Nitsche, Dietrich; W-2300 Kiel 1, Germany
US6022735
8-2-00
 COMPOSITION FOR INTRODUCING NUCLEIC ACID COMPLEXES INTO HIGHER EUCARYOTIC CELLS Boehringer Ingelheim International GmbH Germany Genentech, Inc., South San Francisco, CA The University of North Carolina at Chapel Hill, Chapel Hill, NC Curiel, David T.; Chapel Hill, NC F25 Birnstiel, Max L.;Cotten, Matthew;Wagner, Ernst; Langenzersdorf, Austria Zatloukal, Kurt;Plank, Christian;Oberhauser, Berndt;Schmidt, Walter G. M.;
US5981273
9-11-99
 COMPOSITION COMPRISING AN ENDOSOMOLYTIC AGENT FOR INTRODUCING NUCLEIC ACID COMPLEXES INTO HIGHER EUCARYOTIC CELLS Boehringer Ingelheim International GmbH Germany Genentech, Inc., South San Francisco, CA The University of North Carolina at Chapel Hill, Chapel Hill, NC Curiel, David T.; Chapel Hill, NC F25 Birnstiel, Max L.;Cotten, Matthew;Wagner, Ernst; Langenzersdorf, Austria Zatloukal, Kurt;Plank, Christian;Oberhauser, Berndt;Schmidt, Walter G. M.;
US5922859
12-7-99
 COMPLEXES CONTAINING NUCLEIC ACID WHICH CAN BE TAKENUP BY ENDOCYTOSIS INTO HIGHER EUKARYOTIC CELLS Boehringer Ingelheim International GmbH Germany Genentech, Inc., South San Francisco, CA The University of North Carolina at Chapel Hill, Chapel Hill, NC Curiel, David T.; Chapel Hill, NC F25 Birnstiel, Max L.;Cotten, Matthew;Wagner, Ernst; Langenzersdorf, Austria Zatloukal, Kurt;Plank, Christian;Oberhauser, Berndt;Schmidt, Walter G. M.;
US5547932
20-8-96
 COMPOSITION FOR INTRODUCING NUCLEIC ACID COMPLEXES INTO HIGHER EUCARYOTIC CELLS Boehringer Ingelheim International GmbH Germany Genentech, Inc., South San Francisco, CA The University of North Carolina at Chapel Hill, Chapel Hill, NC Curiel, David T.; Chapel Hill, NC F25 Birnstiel, Max L.;Cotten, Matthew;Wagner, Ernst; Langenzersdorf, Austria Zatloukal, Kurt;Plank, Christian;Oberhauser, Berndt;Schmidt, Walter G. M.;
US5521291
28-5-96
 CONJUGATES FOR INTRODUCING NUCLEIC ACID INTO HIGHER EUCARYOTIC CELLS Boehringer Ingelheim International GmbH Germany Genentech, Inc., South San Francisco, CA The University of North Carolina at Chapel Hill, Chapel Hill, NC Curiel, David T.; Chapel Hill, NC F25 Birnstiel, Max L.;Cotten, Matthew;Wagner, Ernst; Langenzersdorf, Austria Zatloukal, Kurt;Plank, Christian;Oberhauser, Berndt;Schmidt, Walter G. M.;
EP1094835A1
2-5-01
 PHARMACEUTICAL COMPOSITION COMPRISING HUMAN APOTRANSFERRIN AND PROCESS FOR MANUFACTURING OF THE COMPOSITION SUOMEN PUNAINEN RISTI VERIPALVELU, Kivihaantie 7, FIN-00310 Helsinki, Finland PARKKINEN, Jaakko; Liinasaarentie 21 B, FIN-02160 Espoo, Finland .VON BONSDORFF-LINDEBERG, Leni; Kirkkotie 14-16 A, FIN-02700 Kauniainen, Finland
EP0533872A1
31-3-93
 USE OF APOTRANSFERRIN WHICH HAS ACCUMULATED ZINC OR COPPER IONS TO COMBAT THE TOXIC ACTION OF ENDOTOXIN Nitsche, Dietrich; W-2300 Kiel 1, Germany Nitsche, Dietrich; W-2300 Kiel 1, Germany
DE59209069CO
29-1-98
 VERWENDUNG VON APOTRANSFERRIN, WELCHES ZINK ODER KUPFERIONEN ANGELAGERT HAT, ZUR BEKAEMPFUNG DER TOXISCHEN WIRKUNG DES ENDOTOXINS Nitsche, Dietrich; W-2300 Kiel 1, Germany Nitsche, Dietrich; W-2300 Kiel 1, Germany
DE4109254C2
25-3-93
 VERWENDUNG VON APOTRANSFERRIN, WELCHES ZINK ODER KUPFERIONEN ANGELAGERT HAT, ZUR BEKAEMPFUNG DER TOXISCHEN WIRKUNG DES ENDOTOXINS Nitsche, Dietrich; W-2300 Kiel 1, Germany Nitsche, Dietrich; W-2300 Kiel 1, Germany
DE4109254A1
24-9-92
 VERWENDUNG VON APOTRANSFERRIN, WELCHES ZWEIWERTIGE KATIONEN ANGELAGERT HAT, ZUR BEKAEMPFUNG DER TOXISCHEN WIRKUNG DES ENDOTOXINS Nitsche, Dietrich; W-2300 Kiel 1, Germany Nitsche, Dietrich; W-2300 Kiel 1, Germany
Home